BBW vs GSK · P/E 12, rev $529.8M vs P/E 13, $103.31B cap
Build-A-Bear Workshop Inc (BBW) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Build-A-Bear Workshop Inc (BBW) is a specialty retail company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported BBW revenue for 2026-01-31 was $529.8M. Net income was $52.2M. Revenue was up 6.7% from 2025-02-01 to 2026-01-31. BBW currently screens at market cap $683.5M and trailing P/E 12.2.
GSK does not have a complete income-statement cache yet.
BBW currently screens at market cap $683.5M and trailing P/E 12.2. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the BBW and GSK stock pages for the full models.
Not investment advice.